Meta-analysis of 6 studies (178 patients) of ozone therapy for medication-related osteonecrosis of the jaw, mainly in oncology: pooled clinical success 71% (95% CI 55%-84%), no adverse effects reported; evidence of very low certainty.
Meta-analysisn = 178
Carneiro et al. Ozone therapy as an adjunctive strategy for MRONJ in oncology patients: A systematic review and meta-analysis